Abatacept for Prophylaxis of Acute and Chronic Graft-Versus-Host-Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis of Cohort Studies. (PubMed, Pediatr Blood Cancer) - Oct 11, 2026 - "Despite limitations inherent to retrospective study designs and cohort heterogeneity, these findings indicate that abatacept is an efficacious and safe addition to GvHD prophylaxis in pediatric HSCT."
Journal • Retrospective data • Acute Graft versus Host Disease • Bone Marrow Transplantation • Chronic Graft versus Host Disease • Graft versus Host Disease • Immunology • Infectious Disease • Pediatrics • Transplantation
|
|
Anne B Verbeek; Caroline A Lindemans; Emilie P Buddingh; Matthijs D Kruizinga
|